(Q40627208)

22 September 2017

1 reference

title

The clinical relevance of the p53 tumour suppressor gene (English)

1 reference

22 September 2017

Dowell SP

1

1 reference

PubMed ID

7919056

22 September 2017

Hall PA

series ordinal

2

1 reference

PubMed ID

7919056

22 September 2017

language of work or name

1 reference

1 June 1994

1 reference

22 September 2017

1 reference

22 September 2017

5

1 reference

22 September 2017

133-145

1 reference

22 September 2017

3

1 reference

Molecular themes in oncogenesis

22 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Cooperation between oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Wild-type p53 can inhibit oncogene-mediated focus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Identification of p53 as a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Regulation of the specific DNA binding function of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Abnormal expression of wild type p53 protein in normal cells of a cancer family patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Tumor suppressor p53: analysis of wild-type and mutant p53 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Chromosome error propagation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

A new TaqI polymorphism in the p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

PCR detection of a neutral CGA/CGG dimorphism in exon 6 of the human p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

P53 in tumour pathology: can we trust immunocytochemistry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Genetic basis for p53 overexpression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

p53 expression is common in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Prognostic significance of p53 overexpression in gastric and colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Increased p53 protein content of colorectal tumours correlates with poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

p53 expression and prognosis in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

Wild-type p53 activates transcription in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

A death in the life of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.1994.TB00409.X

10.1111/J.1365-2303.1994.TB00409.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

7919056